Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
vitamin C + vitamin D + enoxaparin
- Development stage
- Unknown
- Lead developer
- Sanofi
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral, Subcutaneous
01
Overview
Convential medical treatment-Cairo University-COVID-19 refers to a specific therapeutic regimen utilized as a control and baseline treatment in clinical trials conducted by Cairo University for patients recovering from COVID-19. This combination therapy includes Vitamin C (200 mg/day) and Vitamin D (600 IU/day) for their respective antioxidant and immunomodulatory roles, alongside the low-molecular-weight heparin (LMWH) enoxaparin (30 mg every 12 hours) administered subcutaneously for anticoagulation. The regimen is designed to support immune function and prevent thrombotic complications in the post-acute phase of COVID-19 infection, particularly in patients exhibiting immune deficiencies such as T-lymphocyte depletion or altered cytokine levels.
- Other names
- Convential medical treatment-Cairo University-COVID-19Conventional medical treatment (Cairo University COVID-19 protocol)Cairo University COVID-19 Standard Care Regimen
02
Targets
ATIII (Antithrombin III)F10 (Factor Xa)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on vitamin C + vitamin D + enoxaparin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on vitamin C + vitamin D + enoxaparin.